Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Characterization of liver specific promoters in a foamy viral vector pMD09.

Singh AK, Weber C, Varshney A, Gupta S, Kazim SN, Sanal MG, Rethwilm A, Sarin SK.

Acta Virol. 2019;63(2):162-168. doi: 10.4149/av_2019_207.

PMID:
31230445
2.

Foamy Virus Vectors Transduce Visceral Organs and Hippocampal Structures following In Vivo Delivery to Neonatal Mice.

Counsell JR, Karda R, Diaz JA, Carey L, Wiktorowicz T, Buckley SMK, Ameri S, Ng J, Baruteau J, Almeida F, de Silva R, Simone R, Lugarà E, Lignani G, Lindemann D, Rethwilm A, Rahim AA, Waddington SN, Howe SJ.

Mol Ther Nucleic Acids. 2018 Sep 7;12:626-634. doi: 10.1016/j.omtn.2018.07.006. Epub 2018 Aug 3.

3.

Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical Trial.

Kasang C, Kalluvya S, Majinge C, Kongola G, Mlewa M, Massawe I, Kabyemera R, Magambo K, Ulmer A, Klinker H, Gschmack E, Horn A, Koutsilieri E, Preiser W, Hofmann D, Hain J, Müller A, Dölken L, Weissbrich B, Rethwilm A, Stich A, Scheller C.

PLoS One. 2016 Jan 26;11(1):e0146678. doi: 10.1371/journal.pone.0146678. eCollection 2016.

4.

Ex vivo gene delivery to synovium using foamy viral vectors.

Armbruster N, Weber C, Wictorowicz T, Rethwilm A, Scheller C, Steinert AF.

J Gene Med. 2014 Jul-Aug;16(7-8):166-78. doi: 10.1002/jgm.2774.

PMID:
25044583
5.

Evaluation and prediction of the HIV-1 central polypurine tract influence on foamy viral vectors to transduce dividing and growth-arrested cells.

Shityakov S, Förster C, Rethwilm A, Dandekar T.

ScientificWorldJournal. 2014;2014:487969. doi: 10.1155/2014/487969. Epub 2014 Jun 9.

6.

Noncanonical microRNA (miRNA) biogenesis gives rise to retroviral mimics of lymphoproliferative and immunosuppressive host miRNAs.

Kincaid RP, Chen Y, Cox JE, Rethwilm A, Sullivan CS.

mBio. 2014 Apr 8;5(2):e00074. doi: 10.1128/mBio.00074-14.

7.

Specific RNA-protein interactions in the replication of foamy viruses (FVs).

Rethwilm A.

Curr Opin Virol. 2013 Dec;3(6):676-83. doi: 10.1016/j.coviro.2013.09.003. Epub 2013 Oct 8. Review.

PMID:
24119459
8.

Evolution of foamy viruses: the most ancient of all retroviruses.

Rethwilm A, Bodem J.

Viruses. 2013 Sep 25;5(10):2349-74. doi: 10.3390/v5102349. Review.

9.

Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides.

Weber C, Armbruster N, Scheller C, Kreppel F, Kochanek S, Rethwilm A, Steinert AF.

J Gene Med. 2013 Mar-Apr;15(3-4):155-67. doi: 10.1002/jgm.2705.

PMID:
23554302
10.

Construction of a high titer infectious HIV-1 subtype C proviral clone from South Africa.

Jacobs GB, Bock S, Schuch A, Moschall R, Schrom EM, Zahn J, Reuter C, Preiser W, Rethwilm A, Engelbrecht S, Kerkau T, Bodem J.

Viruses. 2012 Sep;4(9):1830-43. doi: 10.3390/v4091830. Epub 2012 Sep 24.

11.

Synthesis and evaluation of hybrid drugs for a potential HIV/AIDS-malaria combination therapy.

Aminake MN, Mahajan A, Kumar V, Hans R, Wiesner L, Taylor D, de Kock C, Grobler A, Smith PJ, Kirschner M, Rethwilm A, Pradel G, Chibale K.

Bioorg Med Chem. 2012 Sep 1;20(17):5277-89. doi: 10.1016/j.bmc.2012.06.038. Epub 2012 Jun 29.

PMID:
22858300
12.

Heparan sulfate is an attachment factor for foamy virus entry.

Plochmann K, Horn A, Gschmack E, Armbruster N, Krieg J, Wiktorowicz T, Weber C, Stirnnagel K, Lindemann D, Rethwilm A, Scheller C.

J Virol. 2012 Sep;86(18):10028-35. doi: 10.1128/JVI.00051-12. Epub 2012 Jul 11.

13.

The prototype foamy virus protease is active independently of the integrase domain.

Spannaus R, Hartl MJ, Wöhrl BM, Rethwilm A, Bodem J.

Retrovirology. 2012 May 10;9:41. doi: 10.1186/1742-4690-9-41.

14.

HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients.

Kasang C, Ulmer A, Donhauser N, Schmidt B, Stich A, Klinker H, Kalluvya S, Koutsilieri E, Rethwilm A, Scheller C.

BMC Infect Dis. 2012 Jan 20;12:14. doi: 10.1186/1471-2334-12-14.

15.

Stimulation of the human RAD51 nucleofilament restricts HIV-1 integration in vitro and in infected cells.

Cosnefroy O, Tocco A, Lesbats P, Thierry S, Calmels C, Wiktorowicz T, Reigadas S, Kwon Y, De Cian A, Desfarges S, Bonot P, San Filippo J, Litvak S, Cam EL, Rethwilm A, Fleury H, Connell PP, Sung P, Delelis O, Andréola ML, Parissi V.

J Virol. 2012 Jan;86(1):513-26. doi: 10.1128/JVI.05425-11. Epub 2011 Oct 19.

16.

Foamy virus biology and its application for vector development.

Lindemann D, Rethwilm A.

Viruses. 2011 May;3(5):561-85. doi: 10.3390/v3050561. Epub 2011 May 11. Review.

17.

HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high.

Kasang C, Kalluvya S, Majinge C, Stich A, Bodem J, Kongola G, Jacobs GB, Mlewa M, Mildner M, Hensel I, Horn A, Preiser W, van Zyl G, Klinker H, Koutsilieri E, Rethwilm A, Scheller C, Weissbrich B.

PLoS One. 2011;6(8):e23091. doi: 10.1371/journal.pone.0023091. Epub 2011 Aug 19.

18.

Regulation of foamy virus protease activity by viral RNA: a novel and unique mechanism among retroviruses.

Hartl MJ, Bodem J, Jochheim F, Rethwilm A, Rösch P, Wöhrl BM.

J Virol. 2011 May;85(9):4462-9. doi: 10.1128/JVI.02211-10. Epub 2011 Feb 16.

19.

Basic residues in the foamy virus Gag protein.

Matthes D, Wiktorowicz T, Zahn J, Bodem J, Stanke N, Lindemann D, Rethwilm A.

J Virol. 2011 Apr;85(8):3986-95. doi: 10.1128/JVI.01906-10. Epub 2011 Feb 2.

20.

Foamy virus nuclear RNA export is distinct from that of other retroviruses.

Bodem J, Schied T, Gabriel R, Rammling M, Rethwilm A.

J Virol. 2011 Mar;85(5):2333-41. doi: 10.1128/JVI.01518-10. Epub 2010 Dec 15.

21.

Complete nucleotide sequence and evolutionary analysis of a gorilla foamy virus.

Schulze A, Lemey P, Schubert J, McClure MO, Rethwilm A, Bodem J.

J Gen Virol. 2011 Mar;92(Pt 3):582-6. doi: 10.1099/vir.0.027011-0. Epub 2010 Nov 24.

PMID:
21106805
22.

Molecular biology of foamy viruses.

Rethwilm A.

Med Microbiol Immunol. 2010 Aug;199(3):197-207. doi: 10.1007/s00430-010-0158-x. Epub 2010 May 6. Review.

PMID:
20445989
23.

An inducible Tet-Off-H2B-GFP lentiviral reporter vector for detection and in vivo isolation of label-retaining cells.

Falkowska-Hansen B, Kollar J, Grüner BM, Schanz M, Boukamp P, Siveke J, Rethwilm A, Kirschner M.

Exp Cell Res. 2010 Jul 1;316(11):1885-95. doi: 10.1016/j.yexcr.2010.02.015. Epub 2010 Feb 18.

PMID:
20171964
24.

Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases.

Hartl MJ, Mayr F, Rethwilm A, Wöhrl BM.

Retrovirology. 2010 Jan 29;7:5. doi: 10.1186/1742-4690-7-5.

25.

Inducible APOBEC3G-Vif double stable cell line as a high-throughput screening platform to identify antiviral compounds.

Nowotny B, Schneider T, Pradel G, Schirmeister T, Rethwilm A, Kirschner M.

Antimicrob Agents Chemother. 2010 Jan;54(1):78-87. doi: 10.1128/AAC.00775-09. Epub 2009 Oct 19.

26.

Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer.

Steinert AF, Proffen B, Kunz M, Hendrich C, Ghivizzani SC, Nöth U, Rethwilm A, Eulert J, Evans CH.

Arthritis Res Ther. 2009;11(5):R148. doi: 10.1186/ar2822. Epub 2009 Oct 2.

27.

Accuracy estimation of foamy virus genome copying.

Gärtner K, Wiktorowicz T, Park J, Mergia A, Rethwilm A, Scheller C.

Retrovirology. 2009 Apr 6;6:32. doi: 10.1186/1742-4690-6-32.

28.

Generation of an improved foamy virus vector by dissection of cis-acting sequences.

Wiktorowicz T, Peters K, Armbruster N, Steinert AF, Rethwilm A.

J Gen Virol. 2009 Feb;90(Pt 2):481-7. doi: 10.1099/vir.0.006312-0.

PMID:
19141459
29.

Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression.

Rothenaigner I, Kramer S, Meggendorfer M, Rethwilm A, Brack-Werner R.

Gene Ther. 2009 Mar;16(3):349-58. doi: 10.1038/gt.2008.173. Epub 2008 Dec 4.

PMID:
19052634
30.

The usefulness of a perfect parasite.

Vassilopoulos G, Rethwilm A.

Gene Ther. 2008 Oct;15(19):1299-1301. No abstract available.

PMID:
18802996
31.

Phylogenetic diversity and low level antiretroviral resistance mutations in HIV type 1 treatment-naive patients from Cape Town, South Africa.

Jacobs GB, Laten A, van Rensburg EJ, Bodem J, Weissbrich B, Rethwilm A, Preiser W, Engelbrecht S.

AIDS Res Hum Retroviruses. 2008 Jul;24(7):1009-12. doi: 10.1089/aid.2008.0028.

PMID:
18593350
32.

Molecular analysis of HIV type 1 vif sequences from Cape Town, South Africa.

Jacobs GB, Nistal M, Laten A, van Rensburg EJ, Rethwilm A, Preiser W, Bodem J, Engelbrecht S.

AIDS Res Hum Retroviruses. 2008 Jul;24(7):991-4. doi: 10.1089/aid.2008.0077.

PMID:
18593349
33.

Characterisation of a chikungunya virus from a German patient returning from Mauritius and development of a serological test.

Kowalzik S, Xuan NV, Weissbrich B, Scheiner B, Schied T, Drosten C, Müller A, Stich A, Rethwilm A, Bodem J.

Med Microbiol Immunol. 2008 Dec;197(4):381-6. doi: 10.1007/s00430-008-0090-5. Epub 2008 Mar 20.

PMID:
18351388
34.

AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP.

Hartl MJ, Kretzschmar B, Frohn A, Nowrouzi A, Rethwilm A, Wöhrl BM.

Nucleic Acids Res. 2008 Feb;36(3):1009-16. Epub 2007 Dec 20.

35.

Complex effects of foamy virus central purine-rich regions on viral replication.

Peters K, Barg N, Gärtner K, Rethwilm A.

Virology. 2008 Mar 30;373(1):51-60. Epub 2008 Feb 20.

36.

The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders.

Koutsilieri E, Rethwilm A, Scheller C.

J Neural Transm Suppl. 2007;(72):43-9. Review.

PMID:
17982877
37.

Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.

Rethwilm A.

Curr Gene Ther. 2007 Aug;7(4):261-71. Review.

PMID:
17969559
38.

AZT-resistant foamy virus.

Kretzschmar B, Nowrouzi A, Hartl MJ, Gärtner K, Wiktorowicz T, Herchenröder O, Kanzler S, Rudolph W, Mergia A, Wöhrl B, Rethwilm A.

Virology. 2008 Jan 5;370(1):151-7. Epub 2007 Sep 27.

39.

The complete nucleotide sequence of a New World simian foamy virus.

Thümer L, Rethwilm A, Holmes EC, Bodem J.

Virology. 2007 Dec 5;369(1):191-7. Epub 2007 Aug 31.

40.

Major biological obstacles for persistent cell-based regeneration of articular cartilage.

Steinert AF, Ghivizzani SC, Rethwilm A, Tuan RS, Evans CH, Nöth U.

Arthritis Res Ther. 2007;9(3):213. Review.

41.

Real-time PCR for diagnosis of human bocavirus infections and phylogenetic analysis.

Neske F, Blessing K, Tollmann F, Schubert J, Rethwilm A, Kreth HW, Weissbrich B.

J Clin Microbiol. 2007 Jul;45(7):2116-22. Epub 2007 May 2.

42.

Structure-activity relationships of flavonoid-induced cytotoxicity on human leukemia cells.

Plochmann K, Korte G, Koutsilieri E, Richling E, Riederer P, Rethwilm A, Schreier P, Scheller C.

Arch Biochem Biophys. 2007 Apr 1;460(1):1-9. Epub 2007 Feb 23.

PMID:
17353006
43.

Dual activity of phosphorothioate CpG oligodeoxynucleotides on HIV: reactivation of latent provirus and inhibition of productive infection in human T cells.

Scheller C, Ullrich A, Lamla S, Dittmer U, Rethwilm A, Koutsilieri E.

Ann N Y Acad Sci. 2006 Dec;1091:540-7.

PMID:
17341643
44.

Acetylation of the foamy virus transactivator Tas by PCAF augments promoter-binding affinity and virus transcription.

Bodem J, Kräusslich HG, Rethwilm A.

J Gen Virol. 2007 Jan;88(Pt 1):259-63.

PMID:
17170459
45.

High-efficiency gene transfer into cultured embryonic motoneurons using recombinant lentiviruses.

Bender FL, Fischer M, Funk N, Orel N, Rethwilm A, Sendtner M.

Histochem Cell Biol. 2007 Apr;127(4):439-48. Epub 2006 Nov 11.

PMID:
17102992
46.

Assessing the risk of transmission of viral diseases in flooded areas: viral load of the River Elbe in Dresden during the flood of August 2002.

Rohayem J, Dumke R, Jaeger K, Schröter-Bobsin U, Mogel M, Kruse A, Jacobs E, Rethwilm A.

Intervirology. 2006;49(6):370-6. Epub 2006 Aug 21.

PMID:
16926550
47.

Genome-wide mapping of foamy virus vector integrations into a human cell line.

Nowrouzi A, Dittrich M, Klanke C, Heinkelein M, Rammling M, Dandekar T, von Kalle C, Rethwilm A.

J Gen Virol. 2006 May;87(Pt 5):1339-47.

PMID:
16603537
48.

The production of cleaved, trimeric human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein vaccine antigens and infectious pseudoviruses using linear polyethylenimine as a transfection reagent.

Kirschner M, Monrose V, Paluch M, Techodamrongsin N, Rethwilm A, Moore JP.

Protein Expr Purif. 2006 Jul;48(1):61-8. Epub 2006 Mar 15.

PMID:
16600625
49.

Caspase inhibition in apoptotic T cells triggers necrotic cell death depending on the cell type and the proapoptotic stimulus.

Scheller C, Knöferle J, Ullrich A, Prottengeier J, Racek T, Sopper S, Jassoy C, Rethwilm A, Koutsilieri E.

J Cell Biochem. 2006 Apr 15;97(6):1350-61.

PMID:
16365881
50.

N-terminal Gag domain required for foamy virus particle assembly and export.

Cartellieri M, Herchenröder O, Rudolph W, Heinkelein M, Lindemann D, Zentgraf H, Rethwilm A.

J Virol. 2005 Oct;79(19):12464-76.

Supplemental Content

Loading ...
Support Center